Singapore could introduce “cruises to nowhere” in bid to help struggling tourism industry

Singapore is hoping to introduce “cruises to nowhere” in an attempt to revive its struggling tourism industry. 

The global cruise industry has taken an enormous hit due to travel restrictions and several outbreaks on ships.

But, Singapore’s tourism board are considering voyages that both depart and return to Singapore.

International students cite “racism” and “PM statement” for not recommending Australia as a study destination

A survey by the Migrant Workers Justice Initiative last month found 59% of more than 5,000 international students were now less likely to recommend Australia as a study destination than before the coronavirus pandemic. 

Survey takers cited rampant racism and discrimination faced by Chinese students and Prime Minister Scott Morrison’s April statement urging students to leave if "they could not support themselves", frequently.

Nigerian-Irish teens develop app to help dementia patients

Nigerian-Irish teens Rachel, Margaret and Joy designed and coded Memory Haven during CoVid-19 lockdown. It’s an app to help people in Ireland living with dementia with music therapy and other features.

According to the 2020 Health Service Executive, there are 55,000 people in Ireland living with dementia.  

Climate change turns Amazon rainforest into Amazon savannah

The Amazon rainforest faces the risk of becoming a savanna as a result of climate change.

Scientists said greenhouse gas emissions have reduced the rainfall the Amazon needs to sustain its ecosystem.

If these rain levels continue to drop, a drier ecosystem could lead to trees dying and an increased risk of fire.

 

India develops the first paper based CoVid-19 test

India developed the Feluda test, which uses Crispr gene-editing technology to detect CoVid-19. Scientists estimate it will show results in under an hour and cost about 500 rupees or 9.52 AUD. 

Researchers at the Delhi based CSIR-Institute of Genomics and Integrative Biology, tested the kit on samples from 2,000 patients, including on CoVid-19 positive patients.